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ABSTRACT
Purpose: To investigate the role of β-(1-3)-D-glucan on 99mTc labelled Escherichia coli translocation and cytokines
secretion in rats submitted to small bowel ischemia/reperfusion injury. Methods: Five groups (n=10 each) of Wistar rats
were subjected to control(C), sham(S), group IR subjected to 45 min of bowel ischemia/60 min of reperfusion(I/R), and
group I/R+glucan  subjected to 45 min of bowel ischemia/60 min of reperfusion(I/R) and injected with 2mg/Kg intramuscular.
Translocation of labelled bacteria to mesenteric lymph nodes, liver, spleen, lung and serum was determined using
radioactivity/count and colony forming units/g(CFU/g). Serum TNFα, IL-1β, IL-6, IL-10 were measured by ELISA. Results:
CFU/g and radioactivity/count were higher in I/R than in I/R+glucan rats. In C, S and S+glucan groups, bacteria and
radioactivity/count were rarely detected. The I/R+glucan rats had enhancement of IL-10 and suppressed production of
serum TNFα, IL-1β and, IL-6, compared to I/R untreated animals. Conclusion: The β-(1-3)-D-glucan modulated the
production of pro-inflammatory and anti-inflammatory cytokines during bowel ischemia/reperfusion, and attenuated
translocation of  labelled bacteria.
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RESUMO
Objetivo: Investigar o papel da β-(1-3)-D-glucana na translocação de  Escherichia coli  marcada com 99mTc e na secreção
de citocinas em ratos submetidos a isquemia e reperfusão intestinal. Métodos: Cinco grupos (n=10 cada) de ratos Wistar
foram denominados controle (C), sham (S),  grupo IR  submetido a 45 minutos de isquemia do intestino delgado e 60
minutos de reperfusão(I/R),  grupo I/R+glucana com 45 minutos de isquemia e 60 minutos de reperfusão(I/R) e tratados
com glucana  2mg/Kg intramuscular.  Translocação de Escherichia coli marcada com 99mTc, para Linfonodos mesentéricos,
fígado, baço, pulmão e soro foi avaliada usando contagem de radioatividade e de unidades formadoras de colônias/g
(UFC/g) Dosagem sérica de TNFα, IL-1β, IL-6, IL-10 foi realizada pelo método ELISA. Resultados: CFU/g e contagem de
radioatividade foi significantemente maior nos ratos do grupo  I/R do que no grupo I/R+glucana. Nos grupos C, S e
S+glucana bactérias e contagem radioativa foram raramente detectadas. Os ratos do grupo I/R+glucana tiveram aumento
de IL-10 sérica e significante redução da expressão de TNFα, IL-1β e IL-6, quando comparados com os animais não
tratados do grupo I/R. Conclusão: A β-(1-3)-D-glucana modulou a produção de citocinas pró-inflamatórias e anti-inflamatórias
durante a isquemia/reperfusão intestinal e contribuiu para reduzir a translocação de bactérias marcadas.
Descritores: Translocação bacteriana. Glucana. Intestino. Isquemia. Reperfusão. Profilaxia.
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Introduction
Maintenance of bacteria and their products in the
intestine is done by both mucin and a layer of epithelial
cells, the intestinal barrier that is essential for health and
survival. These gut cells are in constant division,
metabolizing rapidly and forming an impermeable barrier
to harmful intestinal contents. Because they are
metabolically active, they are also susceptible to oxygen
deprivation with subsequent ischemic damage to
enterocytes and their supporting structures1. This insult
results in epithelial cell damage, decreased absorptive
function, and the loss of basement membrane integrity
leading to translocation of bacteria2.  Bacterial
translocation (BT) was originally defined and described
by Berg and Garlington3 as the passage of viable bacteria
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through the intestinal mucosa into the mesenteric lymph
nodes (MLN) and to other tissues and organs. It has
been suggested that gut ischemia/reperfusion induces
disruption of the intestinal mucosal barrier, allowing
translocation of bacteria and endotoxin from within the
bowel into the blood, an event that may initiate a systemic
inflammatory response and the secretion and activation
of inflammatory mediators, including cytokines4.
Although it has been difficult to show BT in clinical cases,
patients suffering from hemorrhagic shock or post-
surgical syndrome are quite susceptible to endotoxemia
and multiple organ failure5. β-(1-3)-glucan purified from
fungi have been shown to have broad anti-infective
activities6. It have been shown to bind to receptors on
leukocytes and stimulate some immune responses, such
as cytokine release7, and generation of nitric oxide8.
Soluble β-glucan has also been shown to enhance the
clearance of bacteria from the blood, and reduce mortality
in rat sepsis models9. The present experiment was
designed to analyze the effect of soluble β-(1-3)-glucan
in rats submitted to bowel ischemia, with and without
reperfusion, on translocation of  99mTc labelled bacteria
from the intestinal mucosa to MLN, liver, spleen, lung
and serum. Additionally, the levels of serum cytokines
were studied and correlated with BT and β-(1-3)-glucan
administration.
Methods
Radiolabelling of  bacteria
Escherichia coli were labelled with 99mTc, as follows.
Briefly, a sample (0.1 mL) of E. coli ATCC-10536 culture,
grown overnight in soybean casein medium, was
incubated in 10mL of the same medium, under aeration,
for 4 hour at 37ºC. After that, different amounts of
stannous chloride were added to 2 mL of the medium to
reach final concentrations of 40, 130, 290, 400 and 580
mM, respectively. The samples were then incubated at
37ºC for 10, 20, 40 and 60 min. After incubation, 37.0 MBq
of 99mTc were added to each preparation and kept at 37ºC
for 10 min. The tubes were then centrifuged at 3000x g
for 25 min, washed and resuspended with normal saline.
After three washes with saline, the 99mTc E. coli were
incubated at 37ºC for 36h.  Aliquots (100 mL) of
supernatant and resuspended precipitate in saline were
withdrawn for determination of radioactivity. This
procedure was repeated three times. In order to evaluate
the bacterial viability, aliquots were taken from the last
suspension, spread into a solid culture medium and
incubated at 37ºC for 24 h. The effect of the procedure
on the bacterial viability was assessed by comparing the
colony-forming units per mL (CFU/mL) of labelled and
unlabelled E. coli.
Animals
Male Wistar rats weighing 285±14g were maintained
under conditions with controlled temperature, on a 12h
light-dark cycle and fed ad libitum with commercially
available rat chow and water. They were randomly divided
into four groups (n=10 each), and named, respectively: C
group, for non-operated rats, which were the controls, S
group, for sham-operated, I/R for rats submitted to 45
minutes of intestinal ischemia and 60 minutes reperfusion,
and I/R+glucan for those ischemia/reperfusion group
treated with glucan (2mg/Kg) intramuscular. All the
animals were gavaged with 99mTc E. coli, two hours before
the operative procedures. After fasting overnight, the
animals were anesthetized with intramuscular ketamine
(50mg/kg) and xilazine (7mg/kg). In the I/R and I/
R+glucan  groups, the superior mesenteric artery (SMA)
was occluded with a microvascular clamp. The laparotomy
incision was then closed, to be opened 45 minutes later
for removal of the clamp. Reperfusion was confirmed by
the return of pulsation to the mesenteric arcade. The
incision was again closed and the animals were killed
with overdose of anesthetic 60 minutes later.
Glucan administration
For each experiment, soluble β-(1-3)-D-glucan
(Imunoglucan®) was administered intramuscularly to 10
rats of I/R+glucana group, at a dose of  2mg/Kg of body
weight.
Measurement of radioactivity, bacterial counting and
cytokines
At the end of the procedures, under aseptic
conditions, a midline laparotomy was performed and
blood was collected from the portal vein for culture,
counting and cytokines assays. One mL of serum was
aliquoted for radioactivity counting. One gram of MLN
complex, spleen, liver and lung were removed for counting
and culture, if 1g of tissue was available; otherwise, the
entire organ was weighed. Tissues were homogenized
and solubilized. Aliquots of 0.2mL were processed and
were then counted in a PerkinElmer - Wizard TM Gama
Counter. Other portions (0,2mL) were cultured on
selective MacConkey’s agar and blood agar for detection
of gram-negative and gram-positive bacteria,
respectively. The plates were examined after 24 and 48
hours of incubation at 37oC. Portal blood samples were
used for measurement of tumor necrosis factor-alfa
(TNFα), interleukin-1β (IL-1β), interleukin-6 (IL-6), and
interleukin-10 (IL-10) assayed using ELISA. Sensitivity
of detection was 30 pg/ml for all cytokines. Procedures
involving animals and their care were conducted in
conformity with the Guide for the Care and Use of
Laboratory Animals, US National Research Council,
1996. The data analysis were performed using the
BioEstat 2.0 program. The results were tabulated and
compared by ANOVA using post hoc analysis with
Newman-Keuls test. P<=0.05 was considered statistically
significant.
Results
All animals survived the experimental protocol. The
bacterial viability test showed that the number of colony
forming units (CFU) of the E. coli under radiolabelling
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procedure was the same as that grown in absence of
99mTc (data not shown). When the C and S groups were
compared with I/R, and I/R+glucan groups, a significant
variation on the labelled bacteria migration to different
organs was found. As shown in Table 1, the concentration
of radio labelled E. coli was the greatest in the MLN,
lung, and liver in ischemia/reperfusion (IR) rats. So, the
MLN, spleen, liver, lung and serum from I/R rats had
significantly higher levels of radioactivity than did the
organs from the I/R+glucan (p<0.01). The level of
positive cultures with CFU was significantly higher in I/
R rats than in I/R+glucan group (Table 2). The C group
was the only one where the organs and serum were free
of any bacterial colony. In the S group the bacteria were
rarely detected. As observed with the mean count of
radioactivity, bacteria were less detected in the spleen
than in the other organs studied (Tables 1,2). The most
common bacteria cultured from the organs and serum
were E. coli and Enterococcus. TNF-α, IL-1β, IL-6, and
IL-10 were not detected in the serum of the C group,
while there concentrations in the serum of S operated
rats were 41,7±9,4pg/ml, 34±11pg/mL, 144±17pg/mL and,
94±21pg/mL respectively. Significant increase in serum
level of TNF-α (753.7±91pg/ml), IL-1β (588.7±100pg/ml),
IL-6 (422.1±56pg/ml) and, IL-10 (311±52pg/mL) was
observed in I/R group, when compared with C and S rats
(p<0,01). The  I/R+glucan rats had the serum levels of
TNF-α (98±23pg/mL), IL-1β (122±19pg/ml) and, IL-6
(110±31pg/mL) significantly lower than that observed  in
the I/R rats (p<0,01). Nevertheless, an inverse result was
observed in the IL-10. There was a significant increase
(p<0,01) in the level of IL-10 in the I/R+glucan group
when compared to the I/R (Table 3).
TABLE 2 - Magnitude (CFU per gram of tissue) of bacterial translocation to several organs and serum, comparing groups
with and without β-(1-3)-D-glucan intramuscular.
TABLE 1 - Level of radioactivity (mean counts per minute per gram) from MLN, Spleen, Liver, Lung and Serum after 99mTc
E. coli translocation studies.
Groups  n     MLN  Spleen     Liver     Lung   Serum
C 10        0        0     4 ± 1.2     2 ± 1.1     2 ± 0.9
S 10     4 ± 0.9        0        0     3 ± 1.2        0
I/R 10 742 ± 61 * 334 ± 42* 682 ± 83 * 795 ± 132* 420 ± 27*
I/R + Glucan 10 212 ± 29 174 ± 14 322 ± 45 275 ± 95 186 ± 23
C, Control; S, Sham; I/R ischemia/reperfusion; I/R+glucam, ischemia/reperfusion+glucan intramuscular.
* p < 0,01 compared to S, C, I/R+glucan
Groups  n     MLN   Spleen    Liver    Lung     Serum
C 10        0        0        0        0          0
S 10     2 ± 0.2        0        0     4 ± 1.3          0
I/R 10 253 ± 32* 112 ± 12* 178 ± 18* 285 ± 21* 166.5 ± 32*
I/R + Glucan 10   74 ± 18   47 ± 9   82 ± 22   77 ± 12      69 ± 14
C, Control; S, Sham; I/R ischemia/reperfusion; I/R+glucam, ischemia/reperfusion+glucan intramuscular.
*p < 0.01 compared to C, S, I/R+glucan
TABLE 3 - Portal serum levels of cytokines comparing groups with and without β-(1-3)-D-glucan intramuscular.
Groups n TNF-α(pg/mL) IL-1β(pg/mL) IL-6 (pg/mL) IL-10 (pg/mL)
C 10           0           0           0        0
S 10   41,7 ± 9,4*      34 ± 11*    144 ± 17*   94 ± 21*
I/R 10 753.7 ± 91** 588.7 ± 100** 422.1 ± 56** 311 ± 52**
I/R + Glucan 10      98 ± 23    122 ± 19    110 ± 31 430 ± 42
C, Control; S, Sham; I/R ischemia/reperfusion; I/R+glucam, ischemia/reperfusion+glucan intramuscular.
*p<0.01 compared to I/R, and I/R+glucan
** p<0.01 compared to I/R+glucan
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Discussion
The gut has been suggested to be a port of entry for
bacteria after intestinal mucosal injury and endotoxin
challenge10. The translocation process involves the initial
attachment of the bacteria to the gut wall, which by itself
can elicit production of cytokines and initiate the
subsequent inflammatory response. Once intact microbes
penetrate the mucosa, they may be transported to distant
organs of even the systemic circulation11. As shown in
the present study, bowel ischemia and reperfusion
promoted bacteria translocation. In addition, when
compared to the control and sham, this phenomenon was
significantly higher for MLN, spleen, liver, lungs and,
serum in all other groups. Redan et al12 speculate that the
route of BT is through lymphatics into the right side of
the heart and then to the lung. The pulmonary vascular
bed would then represents the first capillary system in
which the translocated bacteria encounter circulating
phagocyte cells.  In fact, a great amount of colony-
forming units of bacteria were found in the lung. The
hypoxia, followed by change in intestinal barrier function,
generates a vicious cycle of increased permeability,
leading to toxic mediators release, and resulting in a
further increase in gut permeability, facilitating the BT13.
However, no significant difference in radioactivity and
CFU were found when they were compared the S group,
where the intestines were gently manipulated, and in  the
C group. In this study, increased serum levels of TNF-α,
IL-1β, IL-6 and IL-10 reflected the ischemia/reperfusion
injury, as demonstrated by other in vivo trials14,15.  It has
been suggested that IL-6 produced by intraepithelial
lymphocytes is responsible for the loss of intestinal
barrier function following hemorrhage, and the extent of
loss can be correlated with plasma levels of this
cytokine16. In the rats treated with soluble β-(1-3)-D-
glucan it was observed a significantly different cytokine
response, which was characterized by decreased
production of TNF-α, IL-1β, and IL-6, suggesting that
immunomodulation with soluble glucan might act to
depress the inflammatory cytokine response. The
decrease in secretion of these pro-inflammatory cytokines
coincided with the increase in IL-10 expression and could,
at least in part, be explained by the action of this cytokine
known to have anti-inflammatory activity. In fact, IL-10
has been shown to inhibit lipopolissacharide-induced
monocyte tissue factor expression in whole blood 17 and
to decrease TNF-α production in human monocytes18. In
a model of murine E. coli sepsis, TNF-α and IL-1 levels
in soluble glucan-treated mice were significantly lower
than in untreated control animals19. The levels of
radioactivity and colony forming units of bacteria on
MLN, spleen, liver, lungs and, serum were lower I/
R+glucan rats than the I/R ones, meaning that the use of
soluble glucan resulted in an overall decrease in bacterial
translocation.
Conclusion
Based on the present data, we conclude that
stimulation of the reticuloendothelial system by soluble
β-(1-3)-D-glucan modulated the production of pro-
inflammatory and anti-inflammatory cytokines during
intestinal ischemia/reperfusion, and attenuated the
translocation of  99mTc labelled bacteria.
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